- Cho YT, Lin JW, Chen YC, et al. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features. J Am Acad Dermatol. 2014;70:539–548.
- Mockenhaupt M. Epidemiology of cutaneous adverse drug reactions. Chem Immunol Allergy. 2017;1:96–108. doi:10.5414/ALX01508E.
- Böhm I, Medina J, Prieto P, Block W, Schild HH. Fixed drug eruption induced by an iodinated non-ionic x-ray contrast medium: a practical approach to identify the causative agent and to prevent its recurrence. Eur Radiol. 2007;17:485–489. doi:10.1007/s00330-006-0371-6.
- Fouchard N, Bertocchi M, Roujeau J-C, Revuz J, Wolkenstein P, Bastuji-Garin S. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115:149–153. doi:10.1046/j.1523-1747.2000.00061.x.
- Weyers W, Metze D. Histopathology of drug eruptions—general criteria, common patterns, and differential diagnosis. Dermatol Pract Concept. 2011;1:33–47. doi:10.5826/dpc.0101a09.
- Elston DM, Stratman EJ, Miller SJ. Skin biopsy. J Am Acad Dermatol. 2016;74:1–16. doi:10.1016/j.jaad.2015.06.033.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 4
Case Studies
Contrast-induced generalized bullous fixed drug eruption resembling Stevens-Johnson syndrome
Meredith GavinSchool of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas; Correspondence[email protected]
http://orcid.org/0000-0003-1340-4170
, BShttp://orcid.org/0000-0003-1340-4170, , MD, , BS, , MD, , MD & , MD